PDF herunterladen
Thromb Haemost 1965; 14(01/02): 088-115
DOI: 10.1055/s-0038-1654857
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Purification and Kinetic Studies on a Circulating Anticoagulant in a Suspected Case of Lupus Erythematosus*

E. T Yin
1   Departments of Biochemistry, Pathology and Medicine, School of Medicine, University of Washington, Seattle, Washington (U.S.A.)
,
L. W Gaston   **
1   Departments of Biochemistry, Pathology and Medicine, School of Medicine, University of Washington, Seattle, Washington (U.S.A.)
› InstitutsangabenThis investigation was supported (in part) by a Public Health Service Research Career Program Award (# AM-8661) from the National Institute of Arthritis and Metabolic Diseases and by a State of Washington Initiative 171 Funds for Research in Biology and Medicine.
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. Juli 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

1. A circulating anticoagulant in a suspected case of lupus erythematosus has been highly purified by a combination of Sephadex gel filtration and DEAE cellulose chromatography.

2. The inhibitor is a gamma globulin with a sedimentation coefficient of 6.6 Svedberg units.

3. For its anticoagulant action, the lupus inhibitor requires a co-factor which is present both in the lupus and normal blood.

4. The cofactor is located in the gamma globulins fraction which is relatively heat stable, but less than the inhibitor, at 56° C.

5. The active lupus inhibitor (inhibitor + cofactor) is not species specific against human prothrombin.

6. Working with highly purified systems, the active inhibitor is found to inhibit prothrombin conversion by formed prothrombin activator. It does not appear to inhibit the formation of prothrombin activator nor does it affect purified prothrombin.

** Present address: Department of Medicine, The Jewish Hospital, St. Louis, Missouri (U.S.A.).


 

  • References

  • 1 Bachmann F, Duckert F, Geiger M, Baer P, Koller F. Differentation of the factor VII complex. Studies on the Stuartprower factor. Thrombos. Diathes. haemorrh. (Stuttg) 01: 169 1957;
    PubMedSuche in Google Scholar
  • 2 Bachmann F, Duckert F, Koller F. The Stuart-Prower factor Assay and its clinical significance. Thrombos. Diathes. haemorrh. (Stuttg) 02: 24 1958;
    PubMedSuche in Google Scholar
  • 3 Biggs R, Denson KWE. The mode of action of a coagulation inhibitor in the blood of two patients with disseminated lupus erythematosus (DLE). : Brit. J. Haemat. 10: 198 1964;
    CrossrefPubMedSuche in Google Scholar
  • 4 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. 3rd ed.,. 378 F.A. Davis Co; Philadelphia: 1962
    Suche in Google Scholar
  • 5 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. 3rd ed.,. 391 F.A. Davis Co; Philadelphia: 1962
    Suche in Google Scholar
  • 6 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. 3rd. ed.,. 385 F.A. Davis Co; Philadelphia: 1962
    Suche in Google Scholar
  • 7 Brecher G, Conkite E. P. Morphology and enumeration of human blood platelets. Amer. J. clin. Path. 23: 15 1953;
    PubMedSuche in Google Scholar
  • 8 Breckenridge R. T, Ratnoff O. D. Studies on the site of action of a circulating anticoagulant in disseminated lupus erythematosus. Amer. J. Med. 35: 813 Dec. 1963;
    CrossrefPubMedSuche in Google Scholar
  • 9 Glauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 187: 373 1956;
    PubMedSuche in Google Scholar
  • 10 Vermylen C, Verstraete M. Antithrombin V: Critical evaluation of its assessment and properties. Thrombos. Diathes. haemorrh. (Stuttg) 05: 267 1960;
    PubMedSuche in Google Scholar
  • 11 Duckert F, Jung E, Schmerling D. H. Hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombos. Diathes. haemorrh. (Stuttg) 05: 179 1960;
    PubMedSuche in Google Scholar
  • 12 Duckert F, Yin E. T, Straub W. Separation and purification of the blood clotting factors by means of chromatography and electrophoresis. Preparative methods. VIII Colloquium. Protides of biological fluids. Sint-Janshospitaal, Brugge, Belgium. May 1960
    PubMedSuche in Google Scholar
  • 13 Fahey J. L, McCoy P. F, Goulian M. Chromatography of serum proteins in normal and pathological sera: The distribution of protein-bound carbohydrate and cholesterol, siderophilin, thyroxinbinding protein, B12-binding protein, alkaline and acid phosphatases, radio- iodinated albumin and myeloma proteins. J. clin. Invest 37: 272 1958;
    CrossrefPubMedSuche in Google Scholar
  • 14 Flodin P, Killander J. Fractionation of human-serum proteins by gel filtration. Biochim. biophys. Acta (Amst) 63: 403 1962;
    CrossrefPubMedSuche in Google Scholar
  • 15 Frick P. G. Acquired circulating anticoagulants in systemic “Collagen disease”. Autoimmune thromboplastin deficiency. Blood 10: 691 1955;
    PubMedSuche in Google Scholar
  • 16 Gaston L. W, Evanger A. E. The requirement for calcium in the thromboplastin generation test. J. Lab, clin. Med. 64: 501 1964;
    PubMedSuche in Google Scholar
  • 17 Gaston L. W, Mach B. F, Beck W. S. Hemophilia A and concurrent factor VII deficiency. New Engl. J. Med. 264: 1078 1961;
    CrossrefPubMedSuche in Google Scholar
  • 18 Gornall A. G, Bardawill G. J, David M. N. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177: 751 1949;
    PubMedSuche in Google Scholar
  • 19 Grabar P. Immunoelectrophoresis analysis. Methods of biochemical analysis. Glick D. ed New York: Interscience Publishers Inc; 7 1 1959
    Suche in Google Scholar
  • 20 Hanahan D. J, Dittmer J. C, Warashina E. A column chromatographic separation of classes of phospholipides. J. Biol. Chem. 228: 685 1957;
    PubMedSuche in Google Scholar
  • 21 Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. clin. Lab. Invest 09 (Supp. 27): 1 1957;
    CrossrefPubMedSuche in Google Scholar
  • 22 Hougie C. Naturally occuring species specific inhibitor of human prothrombin in lupus erythematosus. Proc. Soc. exp. Biol. Med. 116: 359 1964;
    CrossrefPubMedSuche in Google Scholar
  • 23 Kappeler R. Das Verhalten von Faktor V im Serum unter normalen und pathologischen Bedingungen. Z. klin. Med. 153: 103 1955;
    PubMedSuche in Google Scholar
  • 24 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor. Factor VII. Acta haemat. (Basel) 06: 1 1951;
    PubMedSuche in Google Scholar
  • 25 Langdeil R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on One- stage clotting tests. A presumptive test for hemophiliacs and a simple one-stage antihemophilic factor assay procedure. J. Lab. clin. Med. 41: 637 1953;
    PubMedSuche in Google Scholar
  • 26 Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus ? Thrombos. Diathes. haemorrh. (Stuttg) 03: 237 1959;
    PubMedSuche in Google Scholar
  • 27 Margolius Jr. A, Jackson DPO, Ratnoff D. Circulating anticoagulants: Study of 40 cases and review of literature. Medicine 40: 145 1961;
    CrossrefPubMedSuche in Google Scholar
  • 28 Conley C. L, Hartmann R. C. A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J. clin. Invest 31: 621 1952;
    PubMedSuche in Google Scholar
  • 29 Papahadjopoulos D, Yin E. T, Hanahan D. J. Purification and properties of bovine factor X: Molecular changes during activation. Biochem. 03: 1931 1964;
    CrossrefPubMedSuche in Google Scholar
  • 30 Papahadjopoulos D, Yin E. T, Hanahan D. J. To be published..
    PubMed
  • 31 Proctor R. R, Rapaport S. I. The partial thromboplastin time with kaolin. Amer. J. clin. Path. 36: 212 1961;
    PubMedSuche in Google Scholar
  • 32 Rapaport S. I, Ames S. B, Duvall B. J. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood 15: 212 1960;
    CrossrefPubMedSuche in Google Scholar
  • 33 Ratnoff O. D, Menzies C. A New method for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med. 37: 316 1951;
    PubMedSuche in Google Scholar
  • 34 Rouser G, Baumann A. J, KitchevsJcy G, Heller D, O’Brien J. S. Quantitative chromato- graphysic fractionation of complex lipid mixture: Brain lipids. J. Am. Oil Chem. Soc. 38: 544 1961;
    CrossrefPubMedSuche in Google Scholar
  • 35 Schachman H. K. Ultracentrifugation in biochemistry. 55 Academic Press; New York and London: 1959
    Suche in Google Scholar
  • 36 Shulman N. R, Hearon J. Z. Kinetics of conversion of prothrombin to thrombin by biological activators. I. Demonstration of a prothrombin derivative which reacts with proteolytic enzyme inhibitors. J. Biol. Chem. 238 Jan. 1963
    Suche in Google Scholar
  • 37 Streuli F. On the purification and conversion of human prothrombin. Thrombos. Diathes. haemorrh. (Stuttg) 03: 194 1959;
    PubMedSuche in Google Scholar
  • 38 United States Dept, of Health, Education and Welfare. Public Health Service. Laboratory procedures for modern syphilis serology. 1 1961
    PubMedSuche in Google Scholar
  • 39 Waaler B. A. Contact activation in the intrinsic blood clotting system. Scand. J. clin. Lab. Invest 11 (supp. 37): 01: 1959
    PubMed
  • 40 Wintrobe M. M. Clinical hematology. 5th ed.,. 419 Lea and Febiger; Philadelphia: 1961
    Suche in Google Scholar
  • 41 WillTcens R. F, Decher J. L. Rheumatoid arthritis with serologic evidence suggesting lupus erythematosus: Clinical, serologic and chromatographic studies. Arth. Rheumat. 06: 720 1963;
    CrossrefPubMedSuche in Google Scholar
  • 42 Yin E. T. Kinetics of human blood coagulation induced by trypsin. Thrombos. Diathes. haemorrh. (Stuttg) 12: 307 1964;
    PubMedSuche in Google Scholar